Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Blog

Form 8.3 - The Vanguard Group, Inc.: Micro Focus International plc
Form 8.3 - The Vanguard Group, Inc.: Micro Focus International plc
Form 8.3 - The Vanguard Group, Inc.: Micro Focus International plc
eqs_en 
0 10.01.23
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plcPhoto, wide shot, wide-angle lens, Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
eqs_en 
0 10.01.23
Form 8.3 - The Vanguard Group, Inc.: Devro plcPhoto, wide shot, wide-angle lens, Supermarket, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.theapi.app/temp/12c4d93c-5c0e-4e39-8e32-e47404ce9d79.png
Form 8.3 - The Vanguard Group, Inc.: Devro plc
Form 8.3 - The Vanguard Group, Inc.: Devro plc
eqs_en 
0 10.01.23
Form 8.3 - The Vanguard Group, Inc.: Capital & Counties Properties plc
Form 8.3 - The Vanguard Group, Inc.: Capital & Counties Properties plc
Form 8.3 - The Vanguard Group, Inc.: Capital & Counties Properties plc
eqs_en 
0 10.01.23
Rights and Issues Investment Trust PLC: NAV-Net Asset Value(s)Photo, wide shot, wide-angle lens, Private equity firm, sunset photo at golden hour, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/11edc0a6-edfc-46d1-baee-abd4f510abd1.png
Rights and Issues Investment Trust PLC: NAV-Net Asset Value(s)
Rights and Issues Investment Trust PLC: NAV-Net Asset Value(s)
eqs_en 
0 10.01.23
Form 8.3 - The Vanguard Group, Inc.: Biffa plcPhoto, wide shot, wide-angle lens, Janitorial service, Midday, harsh overhead sunlight, directional sunlightt, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/4d4e885c-79e9-4b8f-bd91-e9721cd7c2e9.png
Form 8.3 - The Vanguard Group, Inc.: Biffa plc
Form 8.3 - The Vanguard Group, Inc.: Biffa plc
eqs_en 
0 10.01.23
Form 8.3 - The Vanguard Group, Inc.: AVEVA Group plcPhoto, wide shot, wide-angle lens, soft focus, IT consulting firm, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-uhXP0RHYYxDepjmHeSp1K8bF.png?st=2023-05-07T15%3A26%3A44Z&se=2023-05-07T17%3A26%3A44Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-07T16%3A18%3A55Z&ske=2023-05-08T16%3A18%3A55Z&sks=b&skv=2021-08-06&sig=4pcJOd8aEI1799liUV13F4ElqO7e4RZy8sa1PEeeNZA%3D
Form 8.3 - The Vanguard Group, Inc.: AVEVA Group plc
Form 8.3 - The Vanguard Group, Inc.: AVEVA Group plc
eqs_en 
0 10.01.23
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plcPhoto, wide shot, wide-angle lens, soft focus, Pharmaceutical company, sunset photo at golden hour, photo by Peter Lik: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-TIgKJfhK8q44RPNTTsL9npu7.png?st=2023-05-08T05%3A58%3A04Z&se=2023-05-08T07%3A58%3A04Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-08T02%3A36%3A56Z&ske=2023-05-09T02%3A36%3A56Z&sks=b&skv=2021-08-06&sig=BDDjRcmCPf%2BH//HSxRGZYByMqOKev8lx0/Dhvka/lXk%3D
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
eqs_en 
0 10.01.23
Chelverton UK Dividend Trust plc: NAV-Net Asset Value(s)
Chelverton UK Dividend Trust plc: NAV-Net Asset Value(s)
Chelverton UK Dividend Trust plc: NAV-Net Asset Value(s)
eqs_en 
0 10.01.23
EQS-News: Sernova and Evotec on Track to Initiate Clinical Testing of the First iPSC-Derived Islets in Cell Pouch as a Potential Functional Cure for Type 1 Diabetes Photo, wide shot, wide-angle lens, Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
EQS-News: Sernova and Evotec on Track to Initiate Clinical Testing of the First iPSC-Derived Islets in Cell Pouch as a Potential Functional Cure for Type 1 Diabetes
EQS-News: Sernova and Evotec on Track to Initiate Clinical Testing of the First iPSC-Derived Islets in Cell Pouch as a Potential Functional Cure for Type 1 Diabetes
eqs_en 
0 10.01.23
EQS-Adhoc: Approval by the bondholders of ACCENTRO Real Estate AG’s 2020/2023 bond to the refinancing of the 2020/2023 bond
EQS-Adhoc: Approval by the bondholders of ACCENTRO Real Estate AG’s 2020/2023 bond to the refinancing of the 2020/2023 bond
EQS-Adhoc: Approval by the bondholders of ACCENTRO Real Estate AG’s 2020/2023 bond to the refinancing of the 2020/2023 bond
eqs_en 
0 10.01.23
EQS-Adhoc: alstria office REIT-AG: Portfolio valuation as per December 31, 2022 of EUR 4.6 bn
EQS-Adhoc: alstria office REIT-AG: Portfolio valuation as per December 31, 2022 of EUR 4.6 bn
EQS-Adhoc: alstria office REIT-AG: Portfolio valuation as per December 31, 2022 of EUR 4.6 bn
eqs_en 
0 10.01.23
EQS-News: BRAIN Biotech AG: BRAIN Group's Akribion Genomics business will prioritize the development of therapeutic applications within its CRISPR technology platformPhoto, wide shot, wide-angle lens, soft focus, Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-d5U47McddROtnUwv1JIaZvc2.png?st=2023-05-04T16%3A11%3A57Z&se=2023-05-04T18%3A11%3A57Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T16%3A04%3A37Z&ske=2023-05-05T16%3A04%3A37Z&sks=b&skv=2021-08-06&sig=KvGLXJQj4L2uYw31IYBsPpHX4telRq/7natMW2uEF58%3D
EQS-News: BRAIN Biotech AG: BRAIN Group's Akribion Genomics business will prioritize the development of therapeutic applications within its CRISPR technology platform
EQS-News: BRAIN Biotech AG: BRAIN Group's Akribion Genomics business will prioritize the development of therapeutic applications within its CRISPR technology platform
eqs_en 
0 10.01.23
EQS-Adhoc: BRAIN Biotech AG: prioritizing development of therapeutic applications of the Akribion Genomics technology platform (genome-editing)Photo, wide shot, wide-angle lens, soft focus, Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-pKgbwxVSbyTCu0UzPNe8NL8D.png?st=2023-05-04T16%3A02%3A58Z&se=2023-05-04T18%3A02%3A58Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T12%3A13%3A51Z&ske=2023-05-05T12%3A13%3A51Z&sks=b&skv=2021-08-06&sig=%2BhYssNp3W0HiZMxCV64XVELyP8stYUjFhgUVfPrTLyg%3D
EQS-Adhoc: BRAIN Biotech AG: prioritizing development of therapeutic applications of the Akribion Genomics technology platform (genome-editing)
EQS-Adhoc: BRAIN Biotech AG: prioritizing development of therapeutic applications of the Akribion Genomics technology platform (genome-editing)
eqs_en 
0 10.01.23
EQS-News: Changes in the Supervisory Board of Delticom AGPhoto, wide shot, wide-angle lens, Grocery store, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/9a6c3fc6-53ff-4c6e-848b-263660ac3eb0.png
EQS-News: Changes in the Supervisory Board of Delticom AG
EQS-News: Changes in the Supervisory Board of Delticom AG
eqs_en 
0 10.01.23
EQS-News: Medios AG: Successful completion of the acquisition of bbw – Significant expansion of compounding volumePhoto, wide shot, wide-angle lens, Private equity firm, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Edward Burtynsky: https://img.theapi.app/temp/2b695cca-48cb-4195-802a-e3385fb90ec0.png
EQS-News: Medios AG: Successful completion of the acquisition of bbw – Significant expansion of compounding volume
EQS-News: Medios AG: Successful completion of the acquisition of bbw – Significant expansion of compounding volume
eqs_en 
0 10.01.23
EQS-Adhoc: Uniper SE: Personnel changes on the Board of Management of Uniper SE announcedPhoto, wide shot, wide-angle lens, Gas company, Midday, harsh overhead sunlight, directional sunlightt, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/07ff6859-914a-4fdd-8473-abdbac8978f6.png
EQS-Adhoc: Uniper SE: Personnel changes on the Board of Management of Uniper SE announced
EQS-Adhoc: Uniper SE: Personnel changes on the Board of Management of Uniper SE announced
eqs_en 
0 10.01.23
EQS-News: Deutsche Beteiligungs AG: Successful realisation of investment in PmflexPhoto, wide shot, wide-angle lens, Private equity firm, sunset photo at golden hour, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/11edc0a6-edfc-46d1-baee-abd4f510abd1.png
EQS-News: Deutsche Beteiligungs AG: Successful realisation of investment in Pmflex
EQS-News: Deutsche Beteiligungs AG: Successful realisation of investment in Pmflex
eqs_en 
0 10.01.23
EQS-News: Heliad Equity Partners GmbH & Co. KGaA: Enpal closes its Series D round with €200 million in equity
EQS-News: Heliad Equity Partners GmbH & Co. KGaA: Enpal closes its Series D round with €200 million in equity
EQS-News: Heliad Equity Partners GmbH & Co. KGaA: Enpal closes its Series D round with €200 million in equity
eqs_en 
0 10.01.23
EQS-News: Enapter sets production record in Q4 and grows revenue by 75% in 2022
EQS-News: Enapter sets production record in Q4 and grows revenue by 75% in 2022
EQS-News: Enapter sets production record in Q4 and grows revenue by 75% in 2022
eqs_en 
0 10.01.23
EQS-News: Türk Telekom minimizes software license costs with USU solutionPhoto, wide shot, wide-angle lens, soft focus, IT consulting firm, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-uhXP0RHYYxDepjmHeSp1K8bF.png?st=2023-05-07T15%3A26%3A44Z&se=2023-05-07T17%3A26%3A44Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-07T16%3A18%3A55Z&ske=2023-05-08T16%3A18%3A55Z&sks=b&skv=2021-08-06&sig=4pcJOd8aEI1799liUV13F4ElqO7e4RZy8sa1PEeeNZA%3D
EQS-News: Türk Telekom minimizes software license costs with USU solution
EQS-News: Türk Telekom minimizes software license costs with USU solution
eqs_en 
0 10.01.23
EQS-News: DFV Deutsche Familienversicherung AG: New product for the whole family and start of TV advertising
EQS-News: DFV Deutsche Familienversicherung AG: New product for the whole family and start of TV advertising
EQS-News: DFV Deutsche Familienversicherung AG: New product for the whole family and start of TV advertising
eqs_en 
0 10.01.23
Trading Update and Notice of Results
Trading Update and Notice of Results
Trading Update and Notice of Results
eqs_en 
0 10.01.23
EQS-News: Defence Therapeutics Inc.: mRNA WITH DEFENCE’S ACCUMTM PROGRAM HAS BEEN INITIATED
EQS-News: Defence Therapeutics Inc.: mRNA WITH DEFENCE’S ACCUMTM PROGRAM HAS BEEN INITIATED
EQS-News: Defence Therapeutics Inc.: mRNA WITH DEFENCE’S ACCUMTM PROGRAM HAS BEEN INITIATED
eqs_en 
0 10.01.23
EQS-Adhoc: paragon decides on a tender offer of up to CHF 10 million in relation to its outstanding CHF 21 million 4% bonds 2019-2023Photo, wide shot, wide-angle lens, Construction equipment, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Edward Burtynsky: https://img.midjourneyapi.xyz/temp/96af5505-e3c8-4496-bbb7-e4a5eba91e77.png
EQS-Adhoc: paragon decides on a tender offer of up to CHF 10 million in relation to its outstanding CHF 21 million 4% bonds 2019-2023
EQS-Adhoc: paragon decides on a tender offer of up to CHF 10 million in relation to its outstanding CHF 21 million 4% bonds 2019-2023
eqs_en 
0 10.01.23